This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramocki, M. B.
Right arrow Articles by Taparowsky, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramocki, M. B.
Right arrow Articles by Taparowsky, E. J.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 07 1997, 3547-3555, Vol 17, No. 7
Copyright © 1997, American Society for Microbiology

Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis

MB Ramocki, SE Johnson, MA White, CL Ashendel, SF Konieczny and EJ Taparowsky
Department of Biological Sciences, Purdue University, West Lafayette, Indiana 47907-1392, USA.

The ability of basic helix-loop-helix muscle regulatory factors (MRFs), such as MyoD, to convert nonmuscle cells to a myogenic lineage is regulated by numerous growth factor and oncoprotein signaling pathways. Previous studies have shown that H-Ras 12V inhibits differentiation to a skeletal muscle lineage by disrupting MRF function via a mechanism that is independent of the dimerization, DNA binding, and inherent transcriptional activation properties of the proteins. To investigate the intracellular signaling pathway(s) that mediates the inhibition of MRF-induced myogenesis by oncogenic Ras, we tested two transformation- defective H-Ras 12V effector domain variants for their ability to alter terminal differentiation. H-Ras 12V,35S retains the ability to activate the Raf/MEK/mitogen-activated protein (MAP) kinase cascade, whereas H- Ras 12V,40C is unable to interact directly with Raf-1 yet still influences other signaling intermediates, including Rac and Rho. Expression of each H-Ras 12V variant in C3H10T1/2 cells abrogates MyoD- induced activation of the complete myogenic program, suggesting that MAP kinase-dependent and -independent Ras signaling pathways individually block myogenesis in this model system. However, additional studies with constitutively activated Rac1 and RhoA proteins revealed no negative effects on MyoD-induced myogenesis. Similarly, treatment of Ras-inhibited myoblasts with the MEK1 inhibitor PD98059 revealed that elevated MAP kinase activity is not a significant contributor to the H- Ras 12V effect. These data suggest that an additional Ras pathway, distinct from the well-characterized MAP kinase and Rac/Rho pathways known to be important for the transforming function of activated Ras, is primarily responsible for the inhibition of myogenesis by H-Ras 12V.


This article has been cited by other articles:

  • Miyake, T., Alli, N. S., Aziz, A., Knudson, J., Fernando, P., Megeney, L. A., McDermott, J. C. (2009). Cardiotrophin-1 Maintains the Undifferentiated State in Skeletal Myoblasts. J. Biol. Chem. 284: 19679-19693 [Abstract] [Full Text]  
  • Rui, L., Healy, J. I., Blasioli, J., Goodnow, C. C. (2006). ERK Signaling Is a Molecular Switch Integrating Opposing Inputs from B Cell Receptor and T Cell Cytokines to Control TLR4-Driven Plasma Cell Differentiation. J. Immunol. 177: 5337-5346 [Abstract] [Full Text]  
  • Castellani, L., Salvati, E., Alema, S., Falcone, G. (2006). Fine Regulation of RhoA and Rock Is Required for Skeletal Muscle Differentiation. J. Biol. Chem. 281: 15249-15257 [Abstract] [Full Text]  
  • Oliva, J. L., Zarich, N., Martinez, N., Jorge, R., Castrillo, A., Azanedo, M., Garcia-Vargas, S., Gutierrez-Eisman, S., Juarranz, A., Bosca, L., Gutkind, J. S., Rojas, J. M. (2004). The P34G Mutation Reduces the Transforming Activity of K-Ras and N-Ras in NIH 3T3 Cells but Not of H-Ras. J. Biol. Chem. 279: 33480-33491 [Abstract] [Full Text]  
  • Page, J. L., Wang, X., Sordillo, L. M., Johnson, S. E. (2004). MEKK1 Signaling through p38 Leads to Transcriptional Inactivation of E47 and Repression of Skeletal Myogenesis. J. Biol. Chem. 279: 30966-30972 [Abstract] [Full Text]  
  • Wang, X., Thomson, S. R., Starkey, J. D., Page, J. L., Ealy, A. D., Johnson, S. E. (2004). Transforming Growth Factor {beta}1 Is Up-regulated by Activated Raf in Skeletal Myoblasts but Does Not Contribute to the Differentiation-defective Phenotype. J. Biol. Chem. 279: 2528-2534 [Abstract] [Full Text]  
  • Zador, E., Wuytack, F. (2003). Expression of SERCA2a is independent of innervation in regenerating soleus muscle. Am. J. Physiol. Cell Physiol. 285: C853-C861 [Abstract] [Full Text]  
  • Takahashi, C., Bronson, R. T., Socolovsky, M., Contreras, B., Lee, K. Y., Jacks, T., Noda, M., Kucherlapati, R., Ewen, M. E. (2003). Rb and N-ras Function Together To Control Differentiation in the Mouse. Mol. Cell. Biol. 23: 5256-5268 [Abstract] [Full Text]  
  • Ostrovsky, O., Bengal, E. (2003). The Mitogen-activated Protein Kinase Cascade Promotes Myoblast Cell Survival by Stabilizing the Cyclin-dependent Kinase Inhibitor, p21WAF1 Protein. J. Biol. Chem. 278: 21221-21231 [Abstract] [Full Text]  
  • Johansen, L. M., Deppmann, C. D., Erickson, K. D., Coffin, W. F. III, Thornton, T. M., Humphrey, S. E., Martin, J. M., Taparowsky, E. J. (2003). EBNA2 and Activated Notch Induce Expression of BATF. J. Virol. 77: 6029-6040 [Abstract] [Full Text]  
  • Williams, K. L., Zullo, A. J., Kaplan, M. H., Brutkiewicz, R. R., Deppmann, C. D., Vinson, C., Taparowsky, E. J. (2003). BATF Transgenic Mice Reveal a Role for Activator Protein-1 in NKT Cell Development. J. Immunol. 170: 2417-2426 [Abstract] [Full Text]  
  • Eliazer, S., Spencer, J., Ye, D., Olson, E., Ilaria, R. L. Jr. (2003). Alteration of Mesodermal Cell Differentiation by EWS/FLI-1, the Oncogene Implicated in Ewing's Sarcoma. Mol. Cell. Biol. 23: 482-492 [Abstract] [Full Text]  
  • Johnson, S. E., Dorman, C. M., Bolanowski, S. A. (2002). Inhibition of myogenin Expression by Activated Raf Is Not Responsible for the Block to Avian Myogenesis. J. Biol. Chem. 277: 28742-28748 [Abstract] [Full Text]  
  • Grana, T. M., Rusyn, E. V., Zhou, H., Sartor, C. I., Cox, A. D. (2002). Ras Mediates Radioresistance through Both Phosphatidylinositol 3-Kinase-dependent and Raf-dependent but Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase-independent Signaling Pathways. Cancer Res. 62: 4142-4150 [Abstract] [Full Text]  
  • Pallafacchina, G., Calabria, E., Serrano, A. L., Kalhovde, J. M., Schiaffino, S. (2002). A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl. Acad. Sci. USA 99: 9213-9218 [Abstract] [Full Text]  
  • Kontaridis, M. I., Liu, X., Zhang, L., Bennett, A. M. (2002). Role of SHP-2 in Fibroblast Growth Factor Receptor-Mediated Suppression of Myogenesis in C2C12 Myoblasts. Mol. Cell. Biol. 22: 3875-3891 [Abstract] [Full Text]  
  • Fedorov, Y. V., Jones, N. C., Olwin, B. B. (2002). Atypical Protein Kinase Cs Are the Ras Effectors That Mediate Repression of Myogenic Satellite Cell Differentiation. Mol. Cell. Biol. 22: 1140-1149 [Abstract] [Full Text]  
  • Adi, S., Bin-Abbas, B., Wu, N.-Y., Rosenthal, S. M. (2002). Early Stimulation and Late Inhibition of Extracellular Signal-Regulated Kinase 1/2 Phosphorylation by IGF-I: A Potential Mechanism Mediating the Switch in IGF-I Action on Skeletal Muscle Cell Differentiation. Endocrinology 143: 511-516 [Abstract] [Full Text]  
  • Meriane, M., Roux, P., Primig, M., Fort, P., Gauthier-Rouvière, C. (2000). Critical Activities of Rac1 and Cdc42Hs in Skeletal Myogenesis: Antagonistic Effects of JNK and p38 Pathways. Mol. Biol. Cell 11: 2513-2528 [Abstract] [Full Text]  
  • Pena, T. L., Chen, S. H., Konieczny, S. F., Rane, S. G. (2000). Ras/MEK/ERK Up-regulation of the Fibroblast KCa Channel FIK Is a Common Mechanism for Basic Fibroblast Growth Factor and Transforming Growth Factor-beta Suppression of Myogenesis. J. Biol. Chem. 275: 13677-13682 [Abstract] [Full Text]  
  • Rochard, P., Rodier, A., Casas, F., Cassar-Malek, I., Marchal-Victorion, S., Daury, L., Wrutniak, C., Cabello, G. (2000). Mitochondrial Activity Is Involved in the Regulation of Myoblast Differentiation through Myogenin Expression and Activity of Myogenic Factors. J. Biol. Chem. 275: 2733-2744 [Abstract] [Full Text]  
  • Winter, B, Arnold, H. (2000). Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J. Cell Sci. 113: 4211-4220 [Abstract]  
  • Carson, J. A., Wei, L. (2000). Integrin signaling's potential for mediating gene expression in hypertrophying skeletal muscle. J. Appl. Physiol. 88: 337-343 [Abstract] [Full Text]  
  • Fernandez, N., Caloca, M. J., Prendergast, G. V., Meinkoth, J. L., Kazanietz, M. G. (2000). Atypical Protein Kinase C-{zeta} Stimulates Thyrotropin-Independent Proliferation in Rat Thyroid Cells. Endocrinology 141: 146-152 [Abstract] [Full Text]  
  • Lee, K. Y., Ladha, M. H., McMahon, C., Ewen, M. E. (1999). The Retinoblastoma Protein Is Linked to the Activation of Ras. Mol. Cell. Biol. 19: 7724-7732 [Abstract] [Full Text]  
  • English, J. M., Pearson, G., Hockenberry, T., Shivakumar, L., White, M. A., Cobb, M. H. (1999). Contribution of the ERK5/MEK5 Pathway to Ras/Raf Signaling and Growth Control. J. Biol. Chem. 274: 31588-31592 [Abstract] [Full Text]  
  • Gallo, R., Serafini, M., Castellani, L., Falcone, G., Alemà, S. (1999). Distinct Effects of Rac1 on Differentiation of Primary Avian Myoblasts. Mol. Biol. Cell 10: 3137-3150 [Abstract] [Full Text]  
  • Quilliam, L. A., Castro, A. F., Rogers-Graham, K. S., Martin, C. B., Der, C. J., Bi, C. (1999). M-Ras/R-Ras3, a Transforming Ras Protein Regulated by Sos1, GRF1, and p120 Ras GTPase-activating Protein, Interacts with the Putative Ras Effector AF6. J. Biol. Chem. 274: 23850-23857 [Abstract] [Full Text]  
  • Janssen, R. A. J., Veenstra, K. G., Jonasch, P., Jonasch, E., Mier, J. W. (1998). Ras- and Raf-induced Down-modulation of Non-muscle Tropomyosin Are MEK-independent. J. Biol. Chem. 273: 32182-32186 [Abstract] [Full Text]  
  • Ramocki, M. B., White, M. A., Konieczny, S. F., Taparowsky, E. J. (1998). A Role for RalGDS and a Novel Ras Effector in the Ras-mediated Inhibition of Skeletal Myogenesis. J. Biol. Chem. 273: 17696-17701 [Abstract] [Full Text]  
  • Miller, M. J., Rioux, L., Prendergast, G. V., Cannon, S., White, M. A., Meinkoth, J. L. (1998). Differential Effects of Protein Kinase A on Ras Effector Pathways. Mol. Cell. Biol. 18: 3718-3726 [Abstract] [Full Text]  
  • Gredinger, E., Gerber, A. N., Tamir, Y., Tapscott, S. J., Bengal, E. (1998). Mitogen-activated Protein Kinase Pathway Is Involved in the Differentiation of Muscle Cells. J. Biol. Chem. 273: 10436-10444 [Abstract] [Full Text]  
  • Weyman, C. M., Wolfman, A. (1998). Mitogen-Activated Protein Kinase Kinase (MEK) Activity Is Required for Inhibition of Skeletal Muscle Differentiation by Insulin-Like Growth Factor 1 or Fibroblast Growth Factor 2. Endocrinology 139: 1794-1800 [Abstract] [Full Text]  
  • Dorman, C. M., Johnson, S. E. (2000). Activated Raf Inhibits Myogenesis through a Mechanism Independent of Activator Protein 1-mediated Myoblast Transformation. J. Biol. Chem. 275: 27481-27487 [Abstract] [Full Text]  
  • Heller, H., Gredinger, E., Bengal, E. (2001). Rac1 Inhibits Myogenic Differentiation by Preventing the Complete Withdrawal of Myoblasts from the Cell Cycle. J. Biol. Chem. 276: 37307-37316 [Abstract] [Full Text]  
  • Tarn, C., Lee, S., Hu, Y., Ashendel, C., Andrisani, O. M. (2001). Hepatitis B Virus X Protein Differentially Activates RAS-RAF-MAPK and JNK Pathways in X-transforming Versus Non-transforming AML12 Hepatocytes. J. Biol. Chem. 276: 34671-34680 [Abstract] [Full Text]